Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Cash from Investing Activities (2019 - 2026)

C4 Therapeutics has reported Cash from Investing Activities over the past 8 years, most recently at $16.2 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 44.54% year-over-year to $16.2 million; the TTM value through Mar 2026 reached -$21.6 million, down 169.03%, while the annual FY2025 figure was -$8.6 million, 83.22% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was $16.2 million at C4 Therapeutics, up from -$80.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $57.7 million in Q3 2023 and troughed at -$80.7 million in Q4 2025.
  • A 5-year average of $10.2 million and a median of $15.1 million in 2023 define the central range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 2422.22% in 2025 and fell as far as 690.59% in 2025.
  • Year by year, Cash from Investing Activities stood at $9.3 million in 2022, then soared by 244.09% to $31.9 million in 2023, then tumbled by 57.21% to $13.7 million in 2024, then plummeted by 690.59% to -$80.7 million in 2025, then soared by 120.01% to $16.2 million in 2026.
  • Business Quant data shows Cash from Investing Activities for CCCC at $16.2 million in Q1 2026, -$80.7 million in Q4 2025, and $4.1 million in Q3 2025.